Literature DB >> 33470460

Global and Regional Changes in Perivascular Space in Idiopathic and Familial Parkinson's Disease.

Erin K Donahue1,2, Amjad Murdos3,4, Michael W Jakowec1,2, Nasim Sheikh-Bahaei5,6, Arthur W Toga3,6, Giselle M Petzinger1,2, Farshid Sepehrband3,6.   

Abstract

BACKGROUND: The glymphatic system, including the perivascular space (PVS), plays a critical role in brain homeostasis. Although mounting evidence from Alzheimer's disease has supported the potential role of PVS in neurodegenerative disorders, its contribution in Parkinson's disease (PD) has not been fully elucidated. Although idiopathic (IPD) and familial PD (FPD) share similar pathophysiology in terms of protein aggregation, the differential impact of PVS on PD subtypes remains unknown. Our objective was to examine the differences in PVS volume fraction in IPD and FPD compared to healthy controls (HCs) and nonmanifest carriers (NMCs).
METHODS: A total of 470 individuals were analyzed from the Parkinson's Progression Markers Initiative database, including (1) IPD (n = 179), (2) FPD (LRRK2 [leucine-rich repeat kinase 2], glucocerebrosidase, or α-synuclein) (n = 67), (3) NMC (n = 101), and (4) HCs (n = 84). Total PVS volume fraction (%) was compared using parcellation and quantitation within greater white matter volume at global and regional levels in all cortical and subcortical white matter.
RESULTS: There was a significant increase in global and regional PVS volume fraction in PD versus non-PD, particularly in FPD versus NMC and LRRK2 FPD versus NMC. Regionally, FPD and NMC differed in the medial orbitofrontal region, as did LRRK2 FPD versus NMC. Non-PD and PD differed in the medial orbitofrontal region and the banks of the superior temporal regions. IPD and FPD differed in the cuneus and lateral occipital regions.
CONCLUSIONS: Our findings support the role of PVS in PD and highlight a potentially significant contribution of PVS to the pathophysiology of FPD, particularly LRRK2.
© 2021 International Parkinson and Movement Disorder Society. © 2021 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  imaging; perivascular spaces; α-synuclein; leucine-rich repeat kinase 2; glucocerebrosidase

Mesh:

Substances:

Year:  2021        PMID: 33470460      PMCID: PMC8127386          DOI: 10.1002/mds.28473

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  92 in total

1.  Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers.

Authors:  M Anheim; A Elbaz; S Lesage; A Durr; C Condroyer; F Viallet; P Pollak; B Bonaïti; C Bonaïti-Pellié; A Brice
Journal:  Neurology       Date:  2012-01-25       Impact factor: 9.910

2.  Expression of Aquaporin 1 and Aquaporin 4 in the Temporal Neocortex of Patients with Parkinson's Disease.

Authors:  Akihiko Hoshi; Ayako Tsunoda; Mari Tada; Masatoyo Nishizawa; Yoshikazu Ugawa; Akiyoshi Kakita
Journal:  Brain Pathol       Date:  2016-04-06       Impact factor: 6.508

Review 3.  α-Synuclein pathology in Parkinson's disease and related α-synucleinopathies.

Authors:  Michael X Henderson; John Q Trojanowski; Virginia M-Y Lee
Journal:  Neurosci Lett       Date:  2019-06-03       Impact factor: 3.046

Review 4.  Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.

Authors:  Barry Boland; Wai Haung Yu; Olga Corti; Bertrand Mollereau; Alexandre Henriques; Erwan Bezard; Greg M Pastores; David C Rubinsztein; Ralph A Nixon; Michael R Duchen; Giovanna R Mallucci; Guido Kroemer; Beth Levine; Eeva-Liisa Eskelinen; Fanny Mochel; Michael Spedding; Caroline Louis; Olivier R Martin; Mark J Millan
Journal:  Nat Rev Drug Discov       Date:  2018-08-17       Impact factor: 84.694

5.  Attenuated neural response to gamble outcomes in drug-naive patients with Parkinson's disease.

Authors:  Joyce P M van der Vegt; Oliver J Hulme; Simone Zittel; Kristoffer H Madsen; Michael M Weiss; Carsten Buhmann; Bastiaan R Bloem; Alexander Münchau; Hartwig R Siebner
Journal:  Brain       Date:  2013-02-26       Impact factor: 13.501

6.  Comparative study of Parkinson's disease and leucine-rich repeat kinase 2 p.G2019S parkinsonism.

Authors:  Joanne Trinh; Rim Amouri; John E Duda; James F Morley; Matthew Read; Alan Donald; Carles Vilariño-Güell; Christina Thompson; Chelsea Szu Tu; Emil K Gustavsson; Samia Ben Sassi; Emna Hentati; Mourad Zouari; Emna Farhat; Fatma Nabli; Faycel Hentati; Matthew J Farrer
Journal:  Neurobiol Aging       Date:  2013-11-22       Impact factor: 4.673

7.  Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study.

Authors:  Daniel G Healy; Mario Falchi; Sean S O'Sullivan; Vincenzo Bonifati; Alexandra Durr; Susan Bressman; Alexis Brice; Jan Aasly; Cyrus P Zabetian; Stefano Goldwurm; Joaquim J Ferreira; Eduardo Tolosa; Denise M Kay; Christine Klein; David R Williams; Connie Marras; Anthony E Lang; Zbigniew K Wszolek; Jose Berciano; Anthony H V Schapira; Timothy Lynch; Kailash P Bhatia; Thomas Gasser; Andrew J Lees; Nicholas W Wood
Journal:  Lancet Neurol       Date:  2008-06-06       Impact factor: 44.182

8.  How astrocyte networks may contribute to cerebral metabolite clearance.

Authors:  Mahdi Asgari; Diane de Zélicourt; Vartan Kurtcuoglu
Journal:  Sci Rep       Date:  2015-10-14       Impact factor: 4.379

9.  Efficient, Distributed and Interactive Neuroimaging Data Analysis Using the LONI Pipeline.

Authors:  Ivo D Dinov; John D Van Horn; Kamen M Lozev; Rico Magsipoc; Petros Petrosyan; Zhizhong Liu; Allan Mackenzie-Graham; Paul Eggert; Douglas S Parker; Arthur W Toga
Journal:  Front Neuroinform       Date:  2009-07-20       Impact factor: 4.081

10.  Microstructural network alterations of olfactory dysfunction in newly diagnosed Parkinson's disease.

Authors:  Ming-Ching Wen; Zheyu Xu; Zhonghao Lu; Ling Ling Chan; Eng King Tan; Louis C S Tan
Journal:  Sci Rep       Date:  2017-10-02       Impact factor: 4.379

View more
  4 in total

Review 1.  The meningeal lymphatic vessels and the glymphatic system: Potential therapeutic targets in neurological disorders.

Authors:  Gaowei Li; Yi Cao; Xin Tang; Jianhan Huang; Linjun Cai; Liangxue Zhou
Journal:  J Cereb Blood Flow Metab       Date:  2022-04-28       Impact factor: 6.960

2.  Longitudinal MRI-visible perivascular space (PVS) changes with long-duration spaceflight.

Authors:  Kathleen E Hupfeld; Sutton B Richmond; Heather R McGregor; Daniel L Schwartz; Madison N Luther; Nichole E Beltran; Igor S Kofman; Yiri E De Dios; Roy F Riascos; Scott J Wood; Jacob J Bloomberg; Ajitkumar P Mulavara; Lisa C Silbert; Jeffrey J Iliff; Rachael D Seidler; Juan Piantino
Journal:  Sci Rep       Date:  2022-05-05       Impact factor: 4.996

3.  Enlarged perivascular spaces and white matter hyperintensities in patients with frontotemporal lobar degeneration syndromes.

Authors:  Ming-Liang Wang; Zheng Sun; Wen-Bin Li; Qiao-Qiao Zou; Peng-Yang Li; Xue Wu; Yue-Hua Li
Journal:  Front Aging Neurosci       Date:  2022-07-28       Impact factor: 5.702

Review 4.  Imaging perivascular space structure and function using brain MRI.

Authors:  Giuseppe Barisano; Kirsten M Lynch; Francesca Sibilia; Haoyu Lan; Nien-Chu Shih; Farshid Sepehrband; Jeiran Choupan
Journal:  Neuroimage       Date:  2022-05-21       Impact factor: 7.400

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.